Staff Profile

Biography

Prof. Tse is dually qualified in public health and pharmaceutical medicine from the UK and is an medical examiner accredited by the UK Royal College of Pathologists. Prior to joining HKMU, Prof. Tse held a joint position as Clinical Reader in Public Health Medicine at the University of Kent appointed to the retirement age and Public Health Consultant at the Medway Council in local government. He served as Professor at the Department of Cardiology and Principal Investigator at the Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University. He is a Visiting Professor at the Faculty of Health and Medical Sciences, University of Surrey, and an Honorary Associate Professor at the School of Pharmacy, UCL. Previously, he held visiting/honorary professorships at the First Affiliated Hospital, Dalian Medical University and Xiamen Cardiovascular Hospital, Xiamen University.

He is currently the Editor-in-Chief of Expert Opinion on Pharmacotherapy and serves on the editorial board of >10 international journals, as expert reviewer for >50 international journals in cardiology, cardiac electrophysiology, cardiovascular biology and epidemiology and reviews for six grant bodies from New Zealand, Poland, Sweden and the UK. He is President-Elect, International Society of Electrocardiology, Member, Board of Trustees, International Society for Noninvasive Electrocardiology (ISHNE) and Nucleus Committee Member, Population Health Section, European Association of Preventive Cardiology of the European Society of Cardiology, and Member, Core Steering Committee, International Cardiovascular and Respiratory Alliance. His research is internationally recognised and he is top 0.05% scholars in Medicine and Cardiology (ScholarGPS, 2024: #3354 out of 30 million scholars, Medicine: #493 and Cardiology: #87), top 2% scientists (Stanford University), top 3 cardiology researcher in China (AD Scientific Index) and Expertscape Top expert in 2025.

Teaching Areas & Research Interests

• Pharmacoepidemiology and pharmacovigilance
• Healthcare big data
• Precision medicine
• Personalised care
• Individualised risk prediction
• Predictive analytics
• Cardiovascular diseases

Selected Publications

Books

• Liu, H., Tse, G., Bhattacharya, P., Wang, X., Tripathy, R.K., Goh, C.H. eds. Springer Nature. (2026) Advanced wearable sensing in clinical practice towards healthcare 5.0. eBook ISBN: 978-3-032-19984-3.
• Liu, H., Tse, G., eds. CRC Press, Taylor & Francis Group. (2025) Cutting-Edge Diagnostic Technologies in Cardiovascular Diseases: Towards Data-Driven Smart Healthcare. ISBN-10: 1032771690. ISBN-13: 978-1032771694. https://doi.org/10.1201/9781003481621.
• Dash, S., Pani, S.K., Abraham, A., Susilo, W., Cheung, B.M.Y., Tse, G., eds. Elsevier. (2024) Internet of Things and Machine Learning for Type I and Type II Diabetes: Use cases. Paperback ISBN: 9780323956864. eBook ISBN: 9780323956932. https://doi.org/10.1016/C2021-0-03583-5.

Book Chapters

• Sze, C.Y., Chung, C.T.S., Liu, T., Tse, G. (2024) Chapter 3: Clinical applicability of QT formulae to correct QT interval. Electrocardiography of Channelopathies: A Primer for the Clinical Cardiologist (Electrocardiography in Cardiac Practice). By Manlio F. Márquez-Murillo, ed. Elsevier. ISBN-10: 0443223440. ISBN-13: 9780443223440. https://doi.org/10.1016/B978-0-443-22344-0.00003-6.
• Li, X., Lee, S., Bazoukis, G., Tse, G.#, Liu, T.# (2022) Clinical Applications of Machine Learning in Heart Failure. In State of the Art in Neural Networks and Their Applications, Volume 2, First Edition. By Ayman S.El-Baz Jasjit Suri, eds. Elsevier.
• Li, K.H.C., Tse, G., Liu, T., Yan, G.X. (2019) Anti-arrhythmic effects of non-antiarrhythmic drugs or therapies. In Management of Cardiac Arrhythmias, Third Edition. By Gan-Xin Yan, Peter R. Kowey, and Charles Antzelevitich, eds. Humana Press.

Journal Articles

• Qi, Z., Liu, J., Gu, T., Wu, N., Liu, J., Zhao, J., Tse, G., Lip, G. Y. H., Chen, K. Y., & Liu, T. (2026). Erythrocytosis after SGLT2 inhibitor initiation and anticoagulated outcomes in atrial fibrillation: a real-world analysis with counterfactual modeling. Cardiovascular diabetology, 10.1186/s12933-026-03117-z. Advance online publication. https://doi.org/10.1186/s12933-026-03117-z.
• Lee, T.T.L., Ju, C., Chan, S.C.L., Chou, O.H.I., Chan, J.S.K., Lee, S., Liu, T., Cheng, S.H., Zhang, Y., Cheung, B.M.Y., Wai, A.K.C., Wei, L., Tse, G.* (2025) Effects of Warfarin on the Risks of Mortality, Acute Heart Failure, and Infection Resolution in Patients With Infective Endocarditis: A Target Trial Emulation. Journal of the American Heart Association. 14:e041965. PMID: 40673512. https://doi.org/10.1161/JAHA.125.041965. Impact factor: 6.1.
• Chan, J.S.K., Satti, D.I., Ching, Y.L.A., Lee, Q., Dee, E.C., Ng, K.., Chou, O.H., Liu, T., Tse, G.*, Lai, A.* (2024) Associations between social determinants of health and cardiovascular and cancer mortality in cancer survivors: a prospective cohort study. European Journal of Preventive Cardiology. zwae318. PMID: 39475480. https://doi.org/10.1093/eurjpc/zwae318. Impact factor: 8.6.
• Zhang, N., Jia, Z., Gu, T., Zheng, Y., Zhang, Y., Song, W., Chen, Z., Li, G., Tse, G.*, Liu, T.* (2023) Associations between modifiable risk factors and frailty: a Mendelian randomisation study. Journal of Epidemiology and Community Health. jech-2023-220882. PMID: 37604674. https://doi.org/10.1136/jech-2023-220882. Impact factor: 6.3.
• Zhang, N., Wei, Z., Zhang, Y., Zhang, Q., Chen, Z., Tse, G., Li, G., Liu, T., Wu, S. (2023) Association of Life's Essential 8 with incident atherosclerotic cardiovascular disease in cancer patients: The Kailuan prospective cohort study. European Journal of Preventive Cardiology. zwad256. PMID: 37527528. https://doi.org/10.1093/eurjpc/zwad256. Impact factor: 8.3.
• Chan, J.S.K., Satti, D.I., Dee, E.C., Sharma, G., Virani, S.S., Liu, T.*, Tse, G.* (2023) Association between psychological distress and cardiovascular health amongst cancer survivors in the United States: findings from nationally representative data. European Journal of Preventive Cardiology. 13:zwad162. PMID: 37178316. https://doi.org/10.1093/eurjpc/zwad162. Impact factor: 8.5.
• Tse, G., Shao, Q., Liu, J., Zhang, Y. (2023) The Potential Impact of the 2022 ESC Cardio-Oncology Guidelines on Clinical Practice in China. JACC: CardioOncology. 5(1):153-155. PMID: 36875905. https://doi.org/10.1016/j.jaccao.2023.01.003. Impact factor: 8.4.
• Li, X., Chan, J.S.K., Guan, B., Peng, S., Wu, X., Lu, X., Zhou, J., Hui, J.M.H., Lee, Y.H.A., Satti, D.I., Tsang, S.L., Wu, S., Chen, S., Tse, G.*, Liu, S.* (2022) Triglyceride-glucose index and the risk of heart failure: Evidence from two large cohorts and a mendelian randomization analysis. Cardiovascular Diabetology. 21(1):229. PMID: 36329456. https://doi.org/10.1186/s12933-022-01658-7. Impact factor: 9.0.
• Chan, J.S.K., Tang, P., Ng, K., Dee, E.C., Lee, T.T.L., Chou O.H.I., Lee, Y.H.A., Lau, D.H.H., Liu, T.*, Tse, G.* (2022) Cardiovascular risks of chemo-immunotherapy for lung cancer: a population-based cohort study. Lung Cancer. 174(22):67-70. https://doi.org/10.1016/j.lungcan.2022.10.010. Impact factor: 6.1.
• Lee, T.T.L., Hui, J.M.H., Lee, Y.H.A., Satti, D.I., Shum, Y.K.L., Kiu, P.T.H., Wai, A.K.C., Liu, T., Wong, W.T., Chan, J.S.K., Cheung, B.M.Y., Wong, I.C.K., Cheng, S.H.*, Tse, G.* (2022) Sulfonylurea is associated with higher risks of ventricular arrhythmia or sudden cardiac death compared to metformin: a population-based cohort study. Journal of the American Heart Association. PMID: 36102222. https://doi.org/10.1161/JAHA.122.026289. Impact factor: 5.5.
• Zheng, Y., Zhang, N., Wang, Y., Wang, F., Li, G., Tse, G.*, Liu, T.* (2022) Association between leucocyte telomere length and the risk of atrial fibrillation: an updated systematic review and meta-analysis. Ageing Research Reviews. 81:101707. PMID: 35932977. https://doi.org/10.1016/j.arr.2022.101707. Impact factor: 11.8.
• Chou, O.H.I., Mui, J., Chung, C.T., Radford, D., Ranjithkumar, S., Evbayekha, E., Nam, R., Pay, L., Satti, D.I., Garcia-Zamora, S., Bazoukis, G., Çinier, G., Lee, S., Vassiliou, V.S., Liu, T., Tse, G.*, Wong, I.C.K. Cardiovascular Analytics Group, the International Health Informatics Study Network (2022) COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis. Clinical Research in Cardiology. PMID: 35906423. https://doi.org/10.1007/s00392-022-02070-7. Impact factor: 6.1.
• Lee, Y.H.A., Zhou, J., Hui, J.M.H., Liu, X., Lee, T.T.L., Hui, K., Chan, J.S.K., Wai, A.K.C., Wong, W.T., Liu, T., Ng, K., Lee, S., Dee, E.C., Zhang, Q.*, Tse, G.* (2022) Risk of new-onset prostate cancer for metformin versus sulphonylurea use in type 2 diabetes mellitus: a propensity score-matched study. Journal of the National Comprehensive Cancer Network. 20(6):674-682.e15. PMID: 35714677 https://doi.org/10.6004/jnccn.2022.7010. Impact factor: 12.7.
• Chan, J.S.K., Satti, D.I., Lee, Y.H.A., Hui, J.M.H., Lee, T.T.L., Chou, O.H.I., Wai, A.K.C., Ciobanu, A., Liu, Y., Liu, T., Roever, L., Biondi-Zoccai, G., Zhang, Q., Cheung, B.M.Y., Zhou, J.*, Tse, G.* (2022) High visit-to-visit cholesterol variability predicts new-onset heart failure and adverse cardiovascular events: a retrospective population-based cohort study. European Journal of Preventive Cardiology. PMID: 35653641. https://doi.org/10.1093/eurjpc/zwac097. Impact factor: 8.5.
• Chou, O.H.I., Zhou, J., Lee, T.T.L., Kot, T., Lee, S., Wai, A.K.C., Wong, W.T., Zhang, Q.P., Cheng, S.H., Liu, T., Vassiliou, V.S.*, Cheung, B.M.Y.*, Tse, G.* (2022) Comparisons of the risk of myopericarditis between COVID-19 patients and individuals receiving COVID-19 vaccines: a population-based study. Clinical Research in Cardiology. PMID: 35333945. https://doi.org/10.1007/s00392-022-02007-0. Impact factor: 6.1.
• Tse, G., Liu, T., Roever, L., Lee, S. (2022) The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes. 71(1):e1–e2. PMID: 34995349. https://doi.org/10.2337/db21-0686. Impact factor: 9.5.
• Zhou, J., Lee, S., Wong, W.T., Bin Waleed, K., Leung, K.S.K., Lee, T.T.L., Wai, A.K.C., Liu, T., Chang, C., Cheung, B.M., Zhang, Q.*, Tse, G.* (2021) Gender-specific clinical risk scores incorporating blood pressure variability for predicting incident dementia. Journal of the American Medical Informatics Association. 29(2):335-347. PMID: 34643701. https://doi.org/10.1093/jamia/ocab173. Impact factor: 7.9.
• Zhou, J., Lee, S., Wang, X., Li, Y., Wu, W.K.K., Liu, T., Cao, Z., Zeng, D.D., Leung, K.S.K., Wai, A.K.C., Wong, I.C.K., Cheung, B.M.Y., Zhang, Q.*, Tse, G.* (2021) Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong. NPJ Digital Medicine. 4(1):66. PMID: 33833388. https://doi.org/10.1038/s41746-021-00433-4. Impact factor: 11.7.
• Zhou, J., Lee, S., Guo, C.L., Chang, C., Liu, T., Leung, K.S.K., Wai, A.K.C., Cheung, B.M.Y., Tse, G.*, Zhang, Q.* (2021) Anticoagulant or antiplatelet use and severe COVID-19 disease: a propensity score matched territory-wide study. Pharmacological Research. 165:105473. PMID: 33524539. https://doi.org/10.1016/j.phrs.2021.105473. Impact factor: 10.3.
• Zhou, J., Wang, X., Lee, S., Wu, W.K.K., Cheung, B.M.Y., Zhang, Q.*, Tse, G.* (2020) Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study. Gut. gutjnl-2020-323668. PMID: 33277346. https://doi.org/10.1136/gutjnl-2020-323668. 5-year impact factor: 31.8.

Selected Professional & Community Services

• Member, New Technologies Expert Group, Faculty of Pharmaceutical Medicine, Royal Colleges of Physicians (UK & Ireland)
• Member, Technical Advisory Group on Diabetes, World Health Organization
• Member, Special Interest Group, Academic Public Health & AI and Digital Public Health, Faculty of Public Health (UK)
• Member, Core Steering Committee, International Cardiovascular and Respiratory Alliance
• Nucleus Committee Member, Population Health Section, European Association of Preventive Cardiology
• Deputy Representative for the EAPC Accreditation and Certification Committees
• Member, International Society for Noninvasive Electrocardiology (ISHNE)-Heart Rhythm Society (HRS) Writing Group on Monitoring
• Secretary, International Society for Noninvasive Electrocardiology (ISHNE)- International Society of Electrocardiology (ISE) Joint Scientific Documents Committee
• Member, Board of Trustees, International Society for Noninvasive Electrocardiology (ISHNE)
• Nucleus Committee Member, Young Community, Board Member, and Secretary to the Council, and President-Elect (2025-2027) International Society of Electrocardiology

Further Information

Link to Google Scholar page

Modified Date: 03 Mar, 2026
Edit Profile